0001214659-22-000947.txt : 20220120 0001214659-22-000947.hdr.sgml : 20220120 20220120165728 ACCESSION NUMBER: 0001214659-22-000947 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220119 FILED AS OF DATE: 20220120 DATE AS OF CHANGE: 20220120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cherrington Julie M CENTRAL INDEX KEY: 0001781315 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 22542945 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-55109.xml PRIMARY DOCUMENT X0306 4 2022-01-19 0001576263 Mirati Therapeutics, Inc. MRTX 0001781315 Cherrington Julie M C/O MIRATI THERAPEUTICS, INC. 3545 CRAY COURT SAN DIEGO CA 92121 true false false false Common Stock 2022-01-19 4 S false 1475 116.07 D 2546 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021. /s/ Vickie Reed, Attorney-in-Fact 2022-01-20